000 01256 a2200337 4500
005 20250518081615.0
264 0 _c20210623
008 202106s 0 0 eng d
022 _a1744-8409
024 7 _a10.1080/1744666X.2020.1714437
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTönshoff, Burkhard
245 0 0 _aImmunosuppressive therapy post-transplantation in children: what the clinician needs to know.
_h[electronic resource]
260 _bExpert review of clinical immunology
_c02 2020
300 _a139-154 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdult
650 0 4 _aChild
650 0 4 _aClinical Protocols
650 0 4 _aDrug Therapy, Combination
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
_xprevention & control
650 0 4 _aGraft Rejection
_xdrug therapy
650 0 4 _aGraft Survival
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xadverse effects
650 0 4 _aInfections
_xetiology
650 0 4 _aKidney Transplantation
650 0 4 _aNeoplasms
_xetiology
773 0 _tExpert review of clinical immunology
_gvol. 16
_gno. 2
_gp. 139-154
856 4 0 _uhttps://doi.org/10.1080/1744666X.2020.1714437
_zAvailable from publisher's website
999 _c30533028
_d30533028